-
Going for the Gold: Experts Debate HER2 and EGFR Exon 20 TKIs as First-Line Therapy
Drs. Zosia Piotrowska and Joshua Sabari sparred on the merits of novel TKIs in the frontline setting during a spirited debate at TTLC 2026.
More Recent News
-
Leading by Example: A Message of Resilience, Gratitude, and Hope
During a special session at TTLC 2026, Dr. Ross Camidge shared his personal journey with lung cancer, discussing its impact on both his professional and personal life.
-
Personalized Lung Cancer Therapies: One Size Does Not Fit All
During the TTLC 2026 Opening Keynote, Dr. John V. Heymach said personalizing lung cancer therapies will require disentangling heterogeneity to understand the underlying factors driving the disease in each patient.